Retatrutide and trizepatide are a recent class of medications that target both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors. These combined receptor agonists https://blakepziz512782.laowaiblog.com/37484082/recent-glp-1-and-gip-receptor-agonists-retatrutide-and-trizepatide